Recursion Pharmaceuticals (RXRX) Exchange Rate Effect (2022 - 2026)

Recursion Pharmaceuticals has reported Exchange Rate Effect for 5 years, with the latest figure at -$3.8 million in Q1 2026.

• For the quarter ending Q1 2026, Exchange Rate Effect fell 179.29% year-over-year to -$3.8 million; the trailing twelve-month figure through Mar 2026 stood at $9.4 million (up 469.81% YoY), and the FY2025 full-year result was $18.0 million, up 629.77% from the prior year.
• Exchange Rate Effect for Q1 2026 stood at -$3.8 million, down from $2.1 million in the prior quarter.
• The five-year high for Exchange Rate Effect was $9.3 million in Q2 2025, with the low at -$3.8 million in Q1 2026.
• Historically, Exchange Rate Effect has averaged $763357.1 across 5 years, with a median of $61000.0 in 2023.
• Annual changes were most pronounced in 2024 — Exchange Rate Effect plunged 10850.0% — and 2025, when it surged 7943.22%.
• Recursion Pharmaceuticals' Exchange Rate Effect stood at -$307000.0 in 2022, then surged by 140.39% to $124000.0 in 2023, then plunged by 2900.0% to -$3.5 million in 2024, then jumped by 160.11% to $2.1 million in 2025, then slumped by 283.61% to -$3.8 million in 2026.
• The last three Exchange Rate Effect figures came in at -$3.8 million (Q1 2026), $2.1 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.